[논문]Grape Resveratrol Increases Serum Adiponectin and Downregulates Inflammatory Genes in Peripheral Blood Mononuclear Cells: A Triple-Blind, Placebo-Controlled, One-Year Clinical Trial in Patients with Stable Coronary Artery Disease

Tomé; -Carneiro, Joã; o; Gonzá; lvez, Manuel; Larrosa, Mar; Yá; ñ; ez-Gascó; n, Marí; a J.; Garcí; a-Almagro, Francisco J.; Ruiz-Ros, José; A.; Tomá; s-Barberá; n, Francisco A.; Garcí; a-Conesa, Marí; a T.; Espí; n, Juan Carlos

doi:10.1007/s10557-012-6427-8

Grape Resveratrol Increases Serum Adiponectin and Downregulates Inflammatory Genes in Peripheral Blood Mononuclear Cells: A Triple-Blind, Placebo-Controlled, One-Year Clinical Trial in Patients with Stable Coronary Artery Disease 원문보기

Cardiovascular drugs and therapy, v.27 no.1, 2013년, pp.37 - 48

Tomé-Carneiro, João (Research Group on Quality, Safety and Bioactivity of Plant Foods, CEBAS-CSIC, 30100 Campus de Espinardo, Murcia, Spain) , Gonzálvez, Manuel (Cardiology Service, Morales Meseguer University Hospital, 30008 Avda. Marqué) , Larrosa, Mar (s de los Velez, Murcia, Spain) , Yáñez-Gascón, María J. (Research Group on Quality, Safety and Bioactivity of Plant Foods, CEBAS-CSIC, 30100 Campus de Espinardo, Murcia, Spain) , García-Almagro, Francisco J. (Research Group on Quality, Safety and Bioactivity of Plant Foods, CEBAS-CSIC, 30100 Campus de Espinardo, Murcia, Spain) , Ruiz-Ros, José (Cardiology Service, Morales Meseguer University Hospital, 30008 Avda. Marqué) , A. (s de los Velez, Murcia, Spain) , Tomás-Barberán, Francisco A. (Cardiology Service, Morales Meseguer University Hospital, 30008 Avda. Marqué) , García-Conesa, María T. (s de los Velez, Murcia, Spain) , Espín, Juan Carlos (Research Group on Quality, Safety and Bioactivity of Plant Foods, CEBAS-CSIC, 30100 Campus de Espinardo, Murcia, Spain)

Abstract ▼ AI-Helper

PurposeThe grape and wine polyphenol resveratrol exerts cardiovascular benefits but evidence from randomized human clinical trials is very limited. We investigated dose-depending effects of a resveratrol-containing grape supplement on stable patients with coronary artery disease (CAD) treated according to currently accepted guidelines for secondary prevention of cardiovascular disease.MethodsIn a triple-blind, randomized, placebo-controlled, one-year follow-up, 3-arm pilot clinical trial, 75 stable-CAD patients received 350 mg/day of placebo, resveratrol-containing grape extract (grape phenolics plus 8 mg resveratrol) or conventional grape extract lacking resveratrol during 6 months, and a double dose for the following 6 months. Changes in circulating inflammatory and fibrinolytic biomarkers were analyzed. Moreover, the transcriptional profiling of inflammatory genes in peripheral blood mononuclear cells (PBMCs) was explored using microarrays and functional gene expression analysis.ResultsAfter 1 year, in contrast to the placebo and conventional grape extract groups, the resveratrol-containing grape extract group showed an increase of the anti-inflammatory serum adiponectin (9.6 %, p = 0.01) and a decrease of the thrombogenic plasminogen activator inhibitor type 1 (PAI-1) (−18.6 %, p = 0.05). In addition, 6 key inflammation-related transcription factors were predicted to be significantly activated or inhibited, with 27 extracellular-space acting genes involved in inflammation, cell migration and T-cell interaction signals presenting downregulation (p < 0.05) in PBMCs. No adverse effects were detected in relation to the study products.ConclusionsChronic daily consumption of a resveratrol-containing grape nutraceutical could exert cardiovascular benefits in stable-CAD patients treated according to current evidence-based standards, by increasing serum adiponectin, preventing PAI-1 increase and inhibiting atherothrombotic signals in PBMCs.Electronic supplementary materialThe online version of this article (doi:10.1007/s10557-012-6427-8) contains supplementary material, which is available to authorized users.

주제어

참고문헌 (49)

1. World Health Organization Prevention of cardiovascular disease. Guidelines for assessment and management of cardiovascular risk 2007 Geneva WHO Press
2. Nabel EG Braunwald E A tale of coronary artery disease and myocardial infarction N Engl J Med 2012 366 54 63 10.1056/NEJMra1112570 22216842

상세보기
3. Benagiano M Azzurri A Ciervo A T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions Proc Natl Acad Sci USA 2003 100 6658 6663 10.1073/pnas.1135726100 12740434

상세보기
4. Lin Z Kumar A SenBanerjee S Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function Circ Res 2005 96 e48 e57 10.1161/01.RES.0000159707.05637.a1 15718498

상세보기
5. Libby P Crea F Clinical implications of inflammation for cardiovascular primary prevention Eur Heart J 2010 31 777 783 10.1093/eurheartj/ehq022 20185554

상세보기
6. Smith SC Jr Benjamin EJ Bonow RO World Heart Federation and the Preventive Cardiovascular Nurses Association AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association J Am Coll Cardiol 2011 58 2432 2446 10.1016/j.jacc.2011.10.824 22055990

상세보기
7. Kazemian P Kazemi-Bajestani SM Alherbish A Steed J Oudit GY The use of ω-3 poly-unsaturated fatty acids in heart failure: a preferential role in patients with diabetes Cardiovasc Drugs Ther 2012 26 311 320 10.1007/s10557-012-6397-x 22644698

상세보기
8. Pauwels EK The protective effect of the mediterranean diet: focus on cancer and cardiovascular risk Med Princ Pract 2011 20 103 111 10.1159/000321197 21252562

상세보기
9. Chen YR Yi FF Li XY Wang CY Chen L Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction Cardiovasc Drugs Ther 2009 23 449 458 10.1007/s10557-009-6198-z 19809869

상세보기
10. Akar F Pektas MB Tufan C Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits Cardiovasc Drugs Ther 2011 25 119 131 10.1007/s10557-010-6255-7 20676927

상세보기
11. Vang O Ahmad N Baile CA What is new for an old molecule? Systematic review and recommendations on the use of resveratrol PLoS One 2011 6 e19881 10.1371/journal.pone.0019881 21698226

상세보기
12. Patel KR Scott E Brown VA Gescher AJ Steward WP Brown K Clinical trials of resveratrol Ann NY Acad Sci 2011 1215 161 169 10.1111/j.1749-6632.2010.05853.x 21261655

상세보기
13. Tome-Carneiro J Gonzalvez M Larrosa M Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients from primary prevention of cardiovascular disease. A triple-blind, 6-months follow-up, placebo-controlled, randomized trial Mol Nutr Food Res 2012 56 810 821 10.1002/mnfr.201100673 22648627

상세보기
14. Cantos E Espin JC Tomas-Barberan FA Postharvest induction modeling method using UV irradiation pulses for obtaining resveratrol-enriched table grapes: a new ‘functional’ fruit? J Agric Food Chem 2001 49 5052 5058 10.1021/jf010366a 11600065

상세보기
15. Tome-Carneiro J Gonzalvez M Larrosa M One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease Am J Cardiol 2012 110 356 363 10.1016/j.amjcard.2012.03.030 22520621

상세보기
16. Azorin-Ortuno M Yanez-Gascon MJ Pallares FJ A dietary resveratrol-rich grape extract prevents the developing of atherosclerotic lesions in the aorta of pigs fed an atherogenic diet J Agric Food Chem 2012 60 5609 5620 10.1021/jf301154q 22594392

상세보기
17. Renaud S de Lorgeril M Wine, alcohol, platelets, and the French paradox for coronary heart disease Lancet 1992 339 1523 1526 10.1016/0140-6736(92)91277-F 1351198

상세보기
18. Zamora-Ros R Andres-Lacueva C Lamuela-Raventos RM Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort Br J Nutr 2008 100 188 196 10.1017/S0007114507882997 18096094

상세보기
19. Stervbo U Vang O Bonnesen C A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine Food Chem 2007 101 449 457 10.1016/j.foodchem.2006.01.047

상세보기
20. Zhu W Cheng KK Vanhoutte PM Lam KS Xu A Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention Clin Sci 2008 114 361 374 10.1042/CS20070347 18230060

상세보기
21. Karastergiou K Evans I Ogston N Epicardial adipokines in obesity and coronary artery disease induce atherogenic changes in monocytes and endothelial cells Arterioscler Thromb Vasc Biol 2010 30 1340 1346 10.1161/ATVBAHA.110.204719 20395594

상세보기
22. Cavusoglu E Ruwende C Chopra V Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain Eur Heart J 2006 27 2300 2309 10.1093/eurheartj/ehl153 16864609

상세보기
23. Teoh H Strauss MH Szmitko PE Verma S Adiponectin and myocardial infarction: a paradox or a paradigm? Eur Heart J 2006 27 2266 2268 10.1093/eurheartj/ehl248 16959802

상세보기
24. Kunita E Yamamoto H Kitagawa T Association between plasma high-molecular-weight adiponectin and coronary plaque characteristics assessed by computed tomography angiography in conditions of visceral adipose accumulation Circ J 2012 76 1687 1696 10.1253/circj.CJ-11-1442 22498563

상세보기
25. Nakamura Y Shimada K Fukuda D Implications of plasma concentrations of adiponectin in patients with coronary artery disease Heart 2004 90 528 533 10.1136/hrt.2003.011114 15084551

상세보기
26. Barseghian A Gawande D Bajaj M Adiponectin and vulnerable atherosclerotic plaques J Am Coll Cardiol 2011 57 761 770 10.1016/j.jacc.2010.11.011 21310310

상세보기
27. Kohler HP Grant PJ Plasminogen-activator inhibitor type 1 and coronary artery disease N Engl J Med 2000 342 1792 1801 10.1056/NEJM200006153422406 10853003

상세보기
28. Belalcazar LM Ballantyne CM Lang W Look Action for Health in Diabetes Research Group Look action for health in diabetes research group. Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the Look AHEAD study Arterioscler Thromb Vasc Biol 2011 31 1689 95 10.1161/ATVBAHA.111.224386 21512162

상세보기
29. Mertens I Ballaux D Funahashi T Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation Thromb Haemost 2005 94 1190 1195 16411393
30. Maruyoshi H Kojima S Funahashi T Adiponectin is inversely related to plasminogen activator inhibitor type 1 in patients with stable exertional angina Thromb Haemost 2004 91 1026 1030 15116265
31. Chan KC Chou HH Huang CN Chou MC Atorvastatin administration after percutaneous coronary intervention in patients with coronary artery disease and normal lipid profiles: impact on plasma adiponectin level Clin Cardiol 2008 31 253 258 10.1002/clc.20181 18543304

상세보기
32. Kaba NK Francis CW Moss AJ Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction J Thromb Haemost 2004 2 718 725 10.1111/j.1538-7836.2004.00658.x 15099276

상세보기
33. Rivera L Moron R Zarzuelo A Galisteo M Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats Biochem Pharmacol 2009 77 1053 1063 10.1016/j.bcp.2008.11.027 19100718

상세보기
34. Olholm J Paulsen SK Cullberg KB Richelsen B Pedersen SB Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants Int J Obes 2010 34 1546 1553 10.1038/ijo.2010.98

상세보기
35. Petrowski G Gurusamy N Das DK Resveratrol in cardiovascular health and disease Ann NY Acad Sci 2011 1215 22 33 10.1111/j.1749-6632.2010.05843.x 21261638

상세보기
36. Azorin-Ortuno M Yanez-Gascon MJ Gonzalez-Sarrias A Effects of long-term consumption of low doses of resveratrol on diet-induced mild hypercholesterolemia in pigs: a transcriptomic approach to disease prevention J Nutr Biochem 2012 23 829 837 10.1016/j.jnutbio.2011.04.007 21852083

상세보기
37. Brasnyo P Molnar GA Mohas M Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients Br J Nutr 2011 106 383 389 10.1017/S0007114511000316 21385509

상세보기
38. Bhatt JK Thomas S Nanjan MJ Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus Nutr Res 2012 32 537 541 10.1016/j.nutres.2012.06.003 22901562

상세보기
39. Magyar K Halmosi R Palfi A Cardioprotection by resveratrol: a human clinical trial in patients with stable coronary artery disease Clin Hemorheol Microcirc 2012 50 179 187 22240353

상세보기
40. Nissen SE Tuzcu EM Schoenhagen P Reversal of atherosclerosis with aggressive lipid lowering (REVERSAL) investigators. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease N Engl J Med 2005 352 29 38 10.1056/NEJMoa042000 15635110

상세보기
41. Albert MA Danielson E Rifai N Ridker PM Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study JAMA 2001 286 64 70 10.1001/jama.286.1.64 11434828

상세보기
42. Ridker PM Rifai N Pfeffer MA Sacks F Braunwald E Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators Circulation 1999 100 230 235 10.1161/01.CIR.100.3.230 10411845

상세보기
43. Kutuk O Basaga H Inflammation meets oxidation: NF-kappaB as a mediator of initial lesion development in atherosclerosis Trends Mol Med 2003 9 549 557 10.1016/j.molmed.2003.10.007 14659470

상세보기
44. Foletta VC Segal DH Cohen DR Transcriptional regulation in the immune system: all roads lead to AP-1 J Leukoc Biol 1998 63 139 152 9468273

상세보기
45. Vo N Goodman RH CREB-binding protein and p300 in transcriptional regulation J Biol Chem 2001 276 13505 13508 11279224

상세보기
46. Azorin-Ortuno M Yanez-Gascon MJ Vallejo F Metabolites and tissue distribution of resveratrol in the pig Mol Nutr Food Res 2011 55 1154 1168 10.1002/mnfr.201100140 21710561

상세보기
47. Steg PG Bhatt DL Wilson PW One-year cardiovascular event rates in outpatients with atherothrombosis JAMA 2007 297 1197 1206 10.1001/jama.297.11.1197 17374814

상세보기
48. Moreno-Palanco MA Ibanez-Sanz P Ciria-de Pablo C Impact of comprehensive and intensive treatment of risk factors concerning cardiovascular mortality in secondary prevention: MIRVAS study Rev Esp Cardiol 2011 64 179 185 10.1016/j.recesp.2010.07.009 21330034

상세보기
49. Steg PG Greenlaw N Tardif JC Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry Eur Heart J 2012 33 2831 2840 10.1093/eurheartj/ehs289 22922505

상세보기

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Grape Resveratrol Increases Serum Adiponectin and Downregulates Inflammatory Genes in Peripheral Blood Mononuclear Cells: A Triple-Blind, Placebo-Controlled, One-Year Clinical Trial in Patients with Stable Coronary Artery Disease 원문보기

Abstract ▼ AI-Helper

주제어

참고문헌 (49)

이 논문을 인용한 문헌

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

연관된 기능

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트